BIO-key (BKYI) announced that it received a notification letter from Nasdaq informing the company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, due to the company’s failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2024. The notification letter has no immediate effect on the listing or trading of the company’s common stock on the Nasdaq Capital Market.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BKYI:
- BIO-key International Delays Annual Report Filing
- BIO-key partners with Arrow ECS Iberia for Channel Alliance Partner program
- BIO-key International Reports Reduced Losses Amid Strategic Shift
- Bio-Key’s Strategic Shift Boosts Margins Amid Revenue Challenges
- BIO-key reports Q4 EPS (53c) vs. ($3.99) last year